Multiple sclerosis (MS) is an autoimmune, inflammatory neurodegenerative disease of the
central nervous system characterized by demyelination and axonal damage. Diagnosis and …

Synthetic MRI is a technique that synthesizes contrast‐weighted images from multicontrast
MRI data. There have been advances in synthetic MRI since the technique was introduced …

A simple blood-derived biomarker is desirable in the routine management of multiple
sclerosis (MS) patients and serum neurofilament light chain (sNfL) is the most promising …

Objective Multiple sclerosis (MS) is associated with cognitive impairment (CI) such as
slowed information processing speed (IPS). Currently, no immunocellular or molecular …

Neurofilaments (NFs) are quickly becoming the biomarkers of choice in the field of
neurology, suggesting their use as an unspecific screening marker, much like the use of …

Multiple sclerosis (MS) is a chronic demyelinating and neuroinflammatory disease of the
human central nervous system with complex pathoetiology, heterogeneous presentations …

Introduction: Multiple Sclerosis (MS) is the most common immune-mediated chronic
neurodegenerative disease of the central nervous system (CNS) affecting young people …

Objective To explore the hypothesis that serum neurofilament light chain (sNfL) indicative of
neuroaxonal damage may improve precise disease profiling with regard to cognition and …

Background Fatigue is common and disabling in multiple sclerosis (MS), yet its mechanisms
are poorly understood. In particular, overlap in measures of fatigue and depression …

Multiple sclerosis (MS) is a debilitating disease of the central nervous system that is most
commonly seen in early to middle adulthood, although it can be diagnosed during childhood …